Knowledge Base

Biosceptre is the worldwide thought leader in using non-functioning P2X7 as a cancer target for therapeutic and diagnostic applications.

Biosceptre’s internationally renowned scientific team has been working in this area for over 20 years, and more recently in conjunction with the Scientific Advisory Board (SAB). The team have authored a significant number of publications and presentations.

This significant knowledge base provides Biosceptre with a distinct and unique advantage over any competitor wanting to enter this market space.